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Abstract. Cutaneous leishmaniasis is endemic to South America where diagnosis is most commonly conducted via
microscopy. Patients with suspected leishmaniasis were referred for enrollment by the Ministry of Health (MoH) in Lima,
Iquitos, Puerto Maldonado, and several rural areas of Peru. A 43-question survey requesting age, gender, occupation,
characterization of the lesion(s), history of leishmaniasis, and insect-deterrent behaviors was administered. Polymerase
chain reaction (PCR) was conducted on lesion materials at the Naval Medical Research Unit No. 6 in Lima, and the results
were compared with those obtained by the MoH using microscopy. Factors associated with negative microscopy and
positive PCR results were identiﬁed using χ2 test, t-test, and multivariate logistic regression analyses. Negative microscopy with positive PCR occurred in 31% (123/403) of the 403 cases. After adjusting for confounders, binary multivariate logistic regression analyses revealed that negative microscopy with positive PCR was associated with patients
who were male (adjusted odds ration [OR] = 1.93 [1.06–3.53], P = 0.032), had previous leishmaniasis (adjusted OR = 2.93
[1.65–5.22], P < 0.0001), had larger lesions (adjusted OR = 1.02 [1.003–1.03], P = 0.016), and/or had a longer duration
between lesion appearance and PCR testing (adjusted OR = 1.12 [1.02–1.22], P = 0.017). Future research should focus on
further exploration of these underlying variables, discovery of other factors that may be associated with negative microscopy diagnosis, and the development and implementation of improved testing in endemic regions.

INTRODUCTION

In most rural clinical laboratories, microscopy is used for
routine diagnosis, creating an opportunity for inaccurate diagnoses, which can impact the patient and the health-care
system.8 False positives may lead to unnecessary therapies with
potentially toxic drugs, whereas false negatives can result in
prolonged disease courses, increased resource utilization for
repeat testing, and greater patient suffering.18 For example, it has
been established that reinfection and drug resistance can occur
if treatment of leishmaniasis is not appropriate or timely.19
Although studies have begun to explore risk factors associated with false-negative PCR results in the diagnosis of
leishmaniasis, few data describe the risk factors for negative
microscopy/positive PCR results, especially in endemic settings.20 This study seeks to elucidate any relationship between demographics, lesion characteristics, and/or insect
deterrent behaviors and negative microscopy/positive PCR
results. This information could prove vital in identifying individuals at risk for false-negative diagnosis, who could beneﬁt
from alternative diagnostic methods or further workup in
leishmaniasis-endemic areas where microscopy is routinely
used for diagnosis.

Leishmaniasis describes a disease caused by infection with
a protozoan parasite in the genus Leishmania, which can
manifest as three forms: cutaneous, mucocutaneous, and
visceral. Leishmaniasis is transmitted to the human host by
the bite of infected phlebotomine sand ﬂies of the genus
Lutzomyia in the New World and Phlebotomus in the Old
World.1–3 This disease is estimated to cause around 51,000
deaths worldwide each year, with global incidence rising
annually.4 Currently, the most common form of leishmaniasis
is cutaneous, with close to 1 million reported cases in the past
5 years.5 Cutaneous leishmaniasis (CL) occurs in the Americas, the Mediterranean Basin, and western Asia (from the
Middle East to Central Asia) with 70–75% of cases occurring in
10 countries: Afghanistan, Algeria, Colombia, Brazil, Iran,
Syria, Ethiopia, North Sudan, Costa Rica, and Peru.6
In developing countries, routine diagnosis of all forms of
leishmaniasis often combines clinical symptoms with direct microscopic examination, serology, and culture. However, clinical
manifestations are often varied and symptoms can be subclinical, whereas culture methods are time-consuming and often
produce no yield.7,8 All of these factors contribute to the low
sensitivity associated with these methods.9 On the other hand,
molecular methods, such as polymerase chain reaction (PCR),
are used primarily in research and approach 99–100% in both
sensitivity and speciﬁcity.10–15 Although direct visualization of
the parasite is the most commonly used technique and often
considered the gold standard of diagnosis for both visceral
leishmaniasis (VL) and CL, there is currently no consensus on
which method should be regularly used.16,17

MATERIALS AND METHODS
Ethics. This study was approved by the Naval Medical
Research Unit No. 6 (NAMRU-6) Institutional Review Board.
Adult participants provided written informed consent and
participants aged 8–17 years provided written informed assent. Parents of participants aged 5–17 years provided written
informed parental consent.
Study design. The parent study of this project was a crosssectional, sentinel surveillance study conducted from 2007 to
2015, which enrolled 485 patients aged 5–65 years at the
following study sites in Peru: Lima, Iquitos, Puerto Maldonado,
as well as other smaller and more remote locations (Figure 1).
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FIGURE 1. Map of lesion collection sites included in this study. This ﬁgure appears in color at www.ajtmh.org.

Individuals who were identiﬁed with suspected or conﬁrmed
CL were referred by Ministry of Health (MoH) staff to one of the
study sites. The study described here is a nested, case–
control study, using 403 eligible cases from the parent study.
Eighty-two cases from the parent study were deemed ineligible and eliminated from the present study because they
were identiﬁed in the military hospital in Lima and did not have
microscopy data to use in the analysis.
Inclusion/exclusion criteria. Inclusion criteria. The inclusion criteria were as follows: 1) participant aged 5–65 years, 2)
laboratory-conﬁrmed case or clinical suspicion of CL (clinical
suspicion consisted of the presence of an erythematous
papule, nodule, plaque, ulcer, or scar at the site of a suspected
sand ﬂy bite, with or without raised and reddened lesion borders, ulcers that were large and painless, unless secondary
infection had occurred, and/or lesions associated with
lymphadenopathy), and 3) signed informed consent/assent.
Exclusion criteria. The exclusion criteria were as follows: 1)
currently under treatment of leishmaniasis or 2) had undergone treatment of leishmaniasis in the past 6 months.
Specimen collection. After explaining the study procedures, risks, and beneﬁts and obtaining informed consent/
assent, a trained MoH health-care worker and/or NAMRU-6
researcher collected the most appropriate clinical samples as
described in the following paragraphs. Preliminary diagnosis
was performed on-site by direct light microscopy examination. Further conﬁrmation of diagnosis and species via PCR

was performed by the NAMRU-6 in Lima. Different collection
methods were used to gather as much clinical data as possible. When applicable, all methods were used to obtain the
samples.
Filter paper sampling. After cleaning the affected skin area
with sterile gauze and alcohol, a 9-cm Fisher-brand, wetstrengthened qualitative ﬁlter paper (Fisher Scientiﬁc, Pittsburgh,
PA) was gently pressed on the ulcer base. The ﬁlter paper was
allowed to air-dry. Then, 10-mm ﬁlter-paper punches were stored
in 1.5-mL microcentrifuge tubes containing 100% ethanol.
Lancet sampling. A cotton swab with 70% ethanol was used
to clean around the lesion border. Using a new, Goldenrod
animal lancet, exudate from the inner margin of the lesion
border was obtained. With this exudate, two slides were made
for microscopy diagnosis on-site at the study locations. Using
a second, new lancet, more exudate from inside the border
region of the lesion was obtained and placed in a microcentrifuge tube (1.5 mL) containing 1 mL of 70% ethanol. With
this exudate, additional two slides were made for an archive
and conﬁrmatory diagnosis at NAMRU-6, Lima.
Biopsy sampling. Local anesthetic (i.e., Xylocaine 5%) was
injected at the border of the clean lesion, and a 3.5–4 mm diameter punch biopsy was obtained from the lesion border.
The biopsy sample was split into 2–3 parts, depending on the
size, and placed in 1.5 mL microfuge tubes containing 1 mL of
70% ethanol. All samples were stored for 1–2 weeks at research sites before being transported to NAMRU-6 facilities
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in Lima. Aliquots from these specimens were used for DNA
isolation and PCR analysis for leishmaniasis diagnosis.
Patient questionnaire. A 43-item questionnaire was administered to each consenting study participant or their legal
guardian to obtain information regarding age, gender, occupation, location, and characterization of the lesion(s), history
of leishmaniasis, insect-deterrent behaviors, and other factors (Supplemental Questionnaire).
Data analysis. Polymerase chain reaction analysis targeting kDNA was conducted on lesion materials obtained from
ﬁlter paper samples, lancet-extracted exudate, and punch
biopsies following protocols described in the literature.21 If a
positive PCR result was obtained from one or more of the
specimens collected from a patient, then he/she was considered positive by PCR. Based on the questionnaire, a preliminary analysis of 131 cases from the research sites in Madre
de Dios was performed. Risk factors found to be associated
with negative microscopy/positive PCR via χ2 test and t-tests
during the initial analysis were included in the present
study’s investigation. The included risk factors were examined
using cross-tabular analyses with χ2 of independence when
data were categorical and independent two-sample t-tests
when data were continuous (nonparametric tests were
also conducted on these data, and ﬁndings were identical).
The factors included in the present analysis were age, gender, occupation, number of lesions, diameter of the lesion,
previous leishmaniasis, time from appearance of the lesion
to PCR-based diagnosis, presence of concurrent mucosal
leishmaniasis, presence of superimposed bacterial infection
of the lesion, and whether the patient’s residence had been
fumigated within the last 6 months.
Of note, for the analysis of occupation, categories included
agricultural workers/wood extractors and gold extractors
(both classiﬁed as high-exposure-to-sand ﬂy groups because
they work outdoors), students (low-exposure group), and
others. The agricultural worker/wood extractor occupation
group was chosen as the reference group based on the hypothesis that this group likely had the highest exposure to
sand ﬂies because workers in these occupations directly encroach on forested sand ﬂy habitats.19
Binary multivariate logistic regression modeling was used to
estimate the adjusted odds of a false-negative microscopy
reading for identiﬁed risk factors, with 95% conﬁdence intervals also being calculated. By convention, all tests of signiﬁcance were two-tailed and evaluated at the level of P < 0.05.
Data analyses were conducted using SAS 9.3 (SAS Institute
Inc., Cary, NC).
Eighty-two cases were not eligible for the study because these
patients presented to Hospital Militar Central in Lima and microscopy data were not readily available to use in the analysis.
Cross-tabular analyses with χ2 test of independence and independent two-sample t-tests were also conducted to elucidate
any differences between the eligible and ineligible groups.
RESULTS
Among the 485 individuals in the parent study who tested
positive for leishmaniasis by PCR, microscopy was not performed on the 82 participants who were excluded from the
nested, case–control study. Demographic, location of enrollment, and occupation data were collected and recorded
(Table 1). Of the 403 eligible individuals with PCR positive
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diagnosis, microscopy yielded 123 negative and 280 positive
results. Using the PCR-obtained results for comparison, microscopy was 56% (157/280) sensitive and 94% (116/123)
speciﬁc for diagnosing leishmaniasis (Table 2).
Patients with negative microscopy/positive PCR results
were ﬁrst compared with patients with all other results using
χ2 test and t-tests. Patients with negative microscopy/positive
PCR were more likely to have larger lesion diameters (24.7
versus 19.9 mm, P = 0.010), multiple lesions (40% versus
28%, P = 0.036), previous history of leishmaniasis (46.2%
versus 26.8%, P = 0.001), and longer duration between lesion
appearance and PCR testing (2.90 versus 2.07 months, P =
0.003). Finally, negative microscopy/positive PCR tended to
occur in younger patients (27.0 versus 29.9 years, P = 0.069),
although this difference was not statistically signiﬁcant
(Table 3). Negative microscopy/positive PCR results were not
signiﬁcantly associated with gender, occupation, concurrent
mucosal leishmaniasis, concurrent bacterial infection of the
lesion, or fumigation of the participant’s residence in the
preceding 6 months.
Binary multivariate logistic regression analyses demonstrated that male patients were almost twice as likely to have
negative microscopy/positive PCR (adjusted OR = 1.93
[1.06–3.53], P = 0.032), patients who had previous leishmaniasis were around three times as likely (adjusted OR = 2.93
[1.65–5.22], P < 0.0001), and patients who had larger lesions
(adjusted OR = 1.02 [1.003–1.03], P = 0.016) and/or had a
longer duration between lesion appearance and PCR testing
(adjusted OR = 1.12 [1.02–1.22], P = 0.017) were also at increased risk for negative microscopy/positive PCR results
(Table 4). Again younger age was seen as marginally statistically related to higher negative microscopy/positive PCR rates
(adjusted OR = 0.98 [0.96–1.002] P = 0.07). Factors that were

TABLE 1
Demographic, location of enrollment, and occupation information for
the 403 cases included in the study
Demographic information

Age (years)
³ 60
50–59
40–49
30–39
20–29
10–19
0–9
N/A
Gender
Male
Female
Location of enrollment
Hospital Militar Central, Lima
Hospital Iquitos, Iquitos
Puerto Maldonado (Centro de Salud Jorge Chavez,
Hospital Santa Rosa, Centro de Salud Nuevo Millenio,
Laboratorio Referencial, Hospital Tambopata, Puesto
de Salud Flor de Acre), Madre de Dios
Delta 1, Madre de Dios
Hospital Iberia, Madre de Dios
Puesto de Salud Otilin, Madre de Dios
Occupation
Agriculture/wood extraction
Gold extraction
Student
Other

Total

17
18
41
79
136
91
18
3
317
86
2
55
258

74
13
1
87
59
96
161
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TABLE 2
Results of microscopy and PCR analysis for the 403 cases included in
this study
PCR results

Microscopy results

+
−
Total

+

−

Total

157
123
280

7
116
123

164
239
403

PCR = polymerase chain reaction.

not signiﬁcantly associated after adjustment included occupation, number of leishmaniasis lesions, concurrent mucosal
leishmaniasis, concurrent bacterial infection of the lesion, and
fumigation of the participant’s residence in the preceding
6 months.
Finally, analyses performed on the 82 ineligible cases found
that compared with the 403 cases eligible for this study, a
higher proportion were male, identiﬁed as students or other for
their occupation, and had a concurrent bacterial infection.
Besides gender, there were no signiﬁcant differences between
those eligible and ineligible regarding any of the variables that
were found to be associated with negative microscopy/
positive PCR results in this study.
DISCUSSION
Our study found that compared with PCR results, microscopy has a sensitivity of 56% in the diagnosis of leishmaniasis.

TABLE 3
Patient demographics, lesion characteristics, and proposed risk factors for participants with negative microscopy/positive PCR as
compared with patients with all other results
False
negative
(N = 123)

Other
(N = 280)

P value

Age in years, mean (SD)
27.0 (13.3) 29.9 (14.8) 0.069
Gender
Male, no. (%)
91 (28.7) 226 (71.3) 0.129
Female, no. (%)
32 (37.2)
54 (62.8)
Occupation
Agriculture/wood extraction,
28 (32.2)
59 (67.8) 0.402
no. (%)
Gold extraction, no. (%)
15 (25.4)
44 (74.6)
Student, no. (%)
35 (36.5)
61 (63.5)
Others, no. (%)
45 (28)
116 (72)
Number of lesions
One, no. (%)
86 (28)
221 (72)
0.036
Two or more, no. (%)
36 (39.6)
55 (60.4)
Diameter of lesion in mm, mean (SD) 24.7 (19.7) 19.9 (15.2) 0.01
Previous leishmaniasis?
Yes, no. (%)
36 (46.2)
42 (53.8) 0.001
No, no. (%)
87 (26.8) 238 (73.2)
Duration from lesion appearance to 2.90 (3.05) 2.07 (2.37) 0.003
PCR testing in months, mean (SD)
Concurrent mucosal leishmaniasis?
Yes, no. (%)
12 (35.3)
22 (64.7) 0.528
No, no. (%)
111 (30.1) 258 (69.9)
Concurrent bacterial infection?
Yes, no. (%)
64 (32.5) 133 (67.5) 0.402
No, no. (%)
59 (28.6) 147 (71.4)
Residence fumigated in past 6
months?
Yes, no. (%)
54 (29.8) 127 (70.2) 0.939
No, no. (%)
64 (30.2) 148 (69.8)
No. = number; PCR = polymerase chain reaction; SD = standard deviation. For categorical
data, cross-tabular analyses with χ2 test of independence were used and for continuous data,
independent two-sample t tests were used.

Leishmaniasis diagnosis is largely based on clinical criteria with
microscopy and visualization being the most commonly used
method of diagnostic detection in rural areas.8 Complicating the
situation is the variability of clinical manifestations of leishmaniasis, rendering clinical diagnosis difﬁcult.22 In addition,
patients in these areas often need a positive diagnosis to receive
aid to pay for treatment. Given these considerations, any ﬂaws in
the diagnostic method are worthy of exploration, especially
because undiagnosed and untreated leishmaniasis can be a
disﬁguring disease, advance to afﬂict mucosal surfaces and
visceral organs, and ultimately become fatal (in the case of
visceral disease).23
This study also identiﬁed statistically signiﬁcant factors that
placed patients at an increased risk of receiving negative
microscopy/positive PCR results. Whereas certain factors,
such as male gender, may be intuitive because of the fact that
males more frequently are used outside and at risk for sand ﬂy
bite, other factors identiﬁed may not. The reasons these selected factors may predispose patients to negative readings
may be explained by reviewing microscopic technique and the
immune response to leishmaniasis infection.
To receive a positive diagnosis of leishmaniasis via microscopy, visualization of amastigotes must be achieved.
However, failure to do so can simply imply low parasite load,
rather than an absence of parasites altogether.24 Sand ﬂy
saliva upregulates various aspects of the immune response,
including complement activation, T-cell proliferation, hematopoiesis, and the activity of antigen-presenting cells.25 This
immune response begins to decrease parasitic load, meaning
chronic leishmaniasis infections demonstrate lower parasitic
loads than acute infections.26
In addition, the host immune response creates the opportunity for acquired immunological resistance to develop in
patients previously infected.27 Therefore, when patients become reinfected, the immune response is augmented, leading
to decreased parasitic load.28 Moreover, multiple lesions are
the result of spread or relapse of the primary infection, or a
concurrent secondary leishmaniasis infection.24 Both of these
scenarios involve a primary immunologic response followed
by either continuation or reactivation of that response which,
as explained previously, leads to decreased parasitic load.
Low parasitic load is also a result of duration of time, in which
the immune system clears the lesion of amastigotes, resulting
in negative microscopy readings the longer the patient waits to
be tested.13,29 This evidence could explain our observation
that longer duration between lesion appearance and PCR
testing, previous leishmaniasis exposure, and multiple lesions
predispose patients to negative microscopy readings.
Another explanation for a low parasitic yield, and subsequent negative microscopy reading, involves acquisition of
the lesion material. The World Health Organization guidelines
recommend that exudative material be taken from the lesion
border, where parasitic load is believed to be higher.30 Although this technique is widely used in ﬁeld sites, more recent
studies have shown that median parasite loads are signiﬁcantly higher in the lesion base and center than in the lesion
border.31,32 This discrepancy could lead to a decreased parasitic yield because most practitioners target the lesion border
for sample collection. This effect could be exacerbated as
distance from the lesion center increases, meaning that a
larger distance between the center of the lesion and the border
could result in an even smaller parasitic yield. This could
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TABLE 4
Adjusted odds ratios for risk factors associated with increased negative microscopy/positive PCR results
Risk factor

Age (years)
Gender (male)
Occupation
Agriculture/wood extraction
Gold extraction
Student
Other
Diameter of lesion
Duration from lesion appearance
to PCR testing
Number of lesions (more than one)
Previous leishmaniasis (yes)
Concurrent mucosal leishmaniasis
(yes)
Concurrent bacterial infection
(yes)
House fumigated in past 6 months
(yes)

OR

95% CI

0.981 0.96–1.002
1.931 1.056–3.528

P value

0.071
0.032

Reference occupation
0.905 0.392–2.091
0.816
1.015 0.465–2.215
0.971
0.665 0.349–1.267
0.215
1.017 1.003–1.031
0.016
1.116 1.020–1.221
0.017
1.545 0.894–2.672
0.119
2.934 1.647–5.224 < 0.0001
1.039 0.437–2.474
0.93
1.158 0.711–1.886

0.555

0.902 0.548–1.486

0.686

CI = conﬁdence interval; PCR = polymerase chain reaction.

explain our observation that larger lesions predispose patients
to negative microscopy results.
The ﬁnding that is perhaps most difﬁcult to explain is the
marginal inverse relationship between age and negative microscopy readings. As per the explanations given previously,
one would expect that younger patients would be leishmaniasis naive and, thus, their immune response would be diminished, resulting in an increased parasitic load. However, an
alternative explanation that could help explain our contradictory observation is that because adult patients are the most
commonly affected population, lesions that are present in
children are largely ignored or misdiagnosed. Thus, when they
are ﬁnally tested, the infection could be more chronic than in
adult patients.28
One ﬁnal hypothesis that may help explain our ﬁndings is
that patients with large lesions, multiple lesions, and/or who
have had the lesion for an extended period of time are more
likely to have used topical substances, which has been shown
to lower the sensitivity of microscopy readings.9
The high prevalence of negative microscopy/positive PCR
readings in the diagnosis of CL demands the development
of high-sensitivity, low-cost, and ﬁeld-deployable diagnostic tests. Currently, there are very few alternatives for CL
diagnosis under development, such as direct boil loopmediated isothermal ampliﬁcation (LAMP).33 By contrast, a
wide set of diagnostic tools have been developed for the detection of VL, such as rapid detection tests for the K3934,35 and
K2836 genes as well as LAMP tests.37 It has been shown that
even though all these methods are feasible in the diagnostic
detection of VL, their use in the diagnosis of CL is equivocal or
of no use.38
The most common types of leishmaniasis in the areas included in this study are those caused by Leishmania amazonensis, braziliensis, mexicana, peruviana, panamensis, and
guyanensis, which most frequently manifest as CL.37,39 This
collection of infections, also known as New World CL, is
similar in countries throughout the West and East Andes;
therefore, the results of our study are largely generalizable to
these regions. In addition, our results are relevant in areas
afﬂicted with Old World CL, such as some areas of Africa
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and the Middle East.40 However, our present study may not be
generalizable to areas in which the species that cause VL,
diffuse, and/or mucosal leishmaniasis are predominant.
Nonetheless, it is worth noting that even in these areas,
leishmaniasis often begins as a cutaneous infection.8
We would like to acknowledge the possibility of measurement bias due to the fact that when sampling was subjected
to PCR analysis, it was performed so using a combination of
samples from all methods of collection (i.e., ﬁlter paper, lancet
sampling, and/or punch biopsy). Lesions were called positive
for leishmaniasis when one of the PCR results from the material collected was positive. However, individual results for
each type of material were not recorded. Therefore, no conclusions can be made regarding the sensitivity and speciﬁcity
of each individual collection method from this study.
In addition, as in most endemic areas, at each of the study
sites, different personnel were responsible for obtaining lesion
exudate and making the primary diagnosis for the patients. This
occurred before members of this research protocol collected
samples used for our analysis and may have introduced some
uncontrolled variability, as those making the initial diagnosis
could have had varying degrees of technical skills and diagnostic
experience. A limitation of this study is our inability to control for
variability among personnel making the initial diagnosis. Because of the low number of samples from certain sites in the
study, we were unable to obtain reliable statistical comparison of
one site’s personnel’s accuracy in diagnosis versus another. One
suggestion for future studies would be to send known leishmaniasis positive and negative microscopic samples to each site
to serve as a control for diagnostic accuracy.
Finally, we do not believe that the 82 excluded cases
compromised the generalizability of our results. These patients
were military individuals enrolled in a survival course at sites in
El Alamo and Alto Amazonas in Peru. During the time of their
infection, as part of the military training, the military personnel
were purposely exposed to extremely poor sanitary conditions.41 These conditions would be abnormal for the average
rural citizen exposed to leishmaniasis and, thus, the inclusion
of these samples would likely jeopardize the generalizability of
our ﬁndings. If these individuals had contracted the disease
while on military duty, not during an artiﬁcially created environment, they certainly would have been included in the analysis.
In conclusion, there exists a need for the development
and implementation of high-sensitivity, low-cost CL diagnostic
tests, especially in resource-poor settings. In the meantime,
certain measures, including highly qualiﬁed and trained professionals collecting samples, standardized diagnostic protocols,
and uniformity of clinical criteria, should be implemented to
minimize the incidence of false-negative diagnoses. Another
potential outcome of this study may involve preemptive referral of patients with risk factors for false-negative diagnoses to facilities that can perform more sensitive
diagnostic tests (e.g., PCR) to prevent detrimental delays in
diagnosis and treatment. In addition, closer and increased
patient follow-up should continue to contribute to ongoing
surveillance of the accuracy of the available diagnostic tests.
These processes are vital in not only preventing more patients from receiving incorrect diagnoses and not receiving
the treatment they require but also in tracking the distribution
of Leishmania parasites and vector populations, which may
be rapidly evolving because of climate change and other
factors.42
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